Back to search
FDAFDA · Food and drugs·Recall number D-1098-2014

Lidocaine 4% Urethral Gel

Published March 12, 2014 · Recall initiated: November 1, 2013

Summary

FDA records drug Class II recall D-1098-2014, published March 12, 2014 and initiated November 1, 2013. Recalling firm: Natures Pharmacy & Compounding Center; Status: Terminated; Reported quantity: 104 syringes; Lot: Lot# 101213, Exp. 04/14 Lot# 09202013, Exp. 03/14 Lot# 08272013, Exp. 02/14 Lot# 08022013, Exp. 01/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Natures Pharmacy & Compounding Center
Distributor
NC
Lot
Lot# 101213, Exp. 04/14 Lot# 09202013, Exp. 03/14 Lot# 08272013, Exp. 02/14 Lot# 08022013, Exp. 01/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine 4% Urethral Gel recalled?

Yes. FDA published recall D-1098-2014 on March 12, 2014. Reported hazard: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone